Charlotte E Teunissen Selected Research

Charlotte E Teunissen Research Topics

Disease

166	Alzheimer Disease (Alzheimer's Disease) 11/2022 - 07/2004
90	Dementia (Dementias) 05/2022 - 01/2005
83	Cognitive Dysfunction 06/2022 - 01/2005
31	Disease Progression 01/2022 - 01/2005
29	Multiple Sclerosis 01/2022 - 01/2005
25	Atrophy 01/2022 - 01/2012
18	Frontotemporal Dementia (Semantic Dementia) 11/2022 - 07/2014
17	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 01/2005
11	Parkinson Disease (Parkinson's Disease) 02/2022 - 01/2005
8	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 10/2022 - 12/2015
8	Inflammation (Inflammations) 01/2022 - 09/2015
6	Amyloidosis 06/2022 - 03/2013
5	Neuroinflammatory Diseases 02/2022 - 01/2011
5	COVID-19 01/2022 - 01/2020
5	Relapsing-Remitting Multiple Sclerosis 11/2021 - 01/2013
5	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 05/2020 - 01/2015
4	Nervous System Diseases (Neurological Disorders) 10/2021 - 01/2016
3	Cerebral Small Vessel Diseases 01/2022 - 07/2014
3	Genetic Risk Score 01/2021 - 11/2020
3	Neuromyelitis Optica (Devic's Disease) 01/2018 - 01/2011
2	Amyloid Plaque 11/2022 - 01/2018
2	Clinical Deterioration 12/2021 - 05/2021
2	Tauopathies 10/2021 - 11/2019
2	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 10/2021 - 01/2021
2	Polyneuropathies (Polyneuropathy) 10/2021 - 10/2021
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 03/2021 - 12/2018
2	Progressive Multifocal Leukoencephalopathy 01/2021 - 01/2019
2	Malnutrition (Nutritional Deficiencies) 01/2020 - 05/2019
2	Fatigue 01/2019 - 08/2013
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019 - 12/2015
2	Hypoxia (Hypoxemia) 12/2018 - 09/2015
2	Chronic Progressive Multiple Sclerosis 11/2018 - 10/2018
2	Neoplasms (Cancer) 10/2018 - 01/2018
1	Paraproteinemias (Monoclonal Gammopathy) 07/2022
1	Monoclonal Gammopathy of Undetermined Significance 07/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 07/2022
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 07/2022
1	Parkinsonian Disorders (Parkinsonism) 02/2022
1	Viral Meningitis 01/2022

Drug/Important Bio-Agent (IBA)

187	Biomarkers (Surrogate Marker)IBA 11/2022 - 07/2004
86	Amyloid (Amyloid Fibrils)IBA 11/2022 - 09/2010
36	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2013
20	Apolipoproteins E (ApoE)IBA 01/2022 - 01/2012
17	Amyloid beta-PeptidesIBA 01/2022 - 05/2013
10	Biological ProductsIBA 05/2022 - 05/2012
10	ApolipoproteinsIBA 01/2020 - 01/2013
8	EnzymesIBA 05/2020 - 05/2013
7	Glial Fibrillary Acidic ProteinIBA 01/2022 - 01/2020
7	AntibodiesIBA 01/2021 - 01/2005
6	Peptides (Polypeptides)IBA 11/2022 - 01/2017
6	Threonine (L-Threonine)FDA Link 11/2022 - 10/2012
6	SynucleinsIBA 02/2022 - 11/2018
6	NeurograninIBA 12/2021 - 10/2015
6	ImmunosorbentsIBA 01/2019 - 05/2013
5	Natalizumab (Tysabri)FDA Link 01/2022 - 01/2019
5	CytokinesIBA 12/2021 - 04/2005
5	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 11/2016
5	Blood Proteins (Serum Proteins)IBA 01/2021 - 01/2018
4	ProteomeIBA 01/2022 - 01/2013
4	Complement System Proteins (Complement)IBA 01/2022 - 06/2012
3	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2021 - 12/2017
3	Protein Isoforms (Isoforms)IBA 12/2020 - 01/2005
3	HomocysteineIBA 10/2020 - 01/2005
3	Pemetrexed (MTA)FDA Link 01/2020 - 01/2012
3	Pharmaceutical PreparationsIBA 11/2016 - 08/2012
2	tau Proteins (tau Protein)IBA 11/2022 - 01/2020
2	Amino Acids FDA Link 11/2022 - 01/2018
2	Protein AggregatesIBA 10/2022 - 10/2018
2	ocrelizumabIBA 01/2022 - 01/2021
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022 - 12/2021
2	Chitinase-3-Like Protein 1IBA 10/2021 - 09/2015
2	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 01/2014
2	HDL LipoproteinsIBA 01/2021 - 10/2020
2	GadoliniumIBA 01/2021 - 01/2020
2	amyloid beta-protein (1-42)IBA 01/2021 - 07/2014
2	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 11/2020 - 11/2020
2	LipidsIBA 10/2020 - 07/2014
2	Folic Acid (Vitamin M)FDA LinkGeneric 10/2020 - 01/2017
2	CholesterolIBA 10/2020 - 01/2016
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 05/2020 - 01/2017
2	UridineIBA 01/2020 - 01/2017
2	Retinaldehyde (Retinal)IBA 12/2019 - 11/2017
2	Biocompatible Materials (Biomaterials)IBA 01/2019 - 12/2014
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2019 - 07/2016
2	glutaminyl-peptide cyclotransferaseIBA 10/2018 - 06/2017
2	Interleukin-6 (Interleukin 6)IBA 11/2017 - 01/2017
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2015 - 01/2014
2	Antihypertensive Agents (Antihypertensives)IBA 01/2015 - 01/2014
2	N-acetylaspartate (N-acetyl aspartate)IBA 12/2014 - 05/2007
1	Apolipoprotein L1IBA 10/2022
1	Immunoglobulin M (IgM)IBA 07/2022
1	ParaproteinsIBA 07/2022
1	Myelin-Associated GlycoproteinIBA 07/2022
1	InflammasomesIBA 02/2022
1	Dopamine (Intropin)FDA LinkGeneric 02/2022
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 02/2022
1	C-Reactive ProteinIBA 01/2022

Therapy/Procedure

14	Therapeutics 07/2022 - 01/2005
2	Highly Active Antiretroviral Therapy (HAART) 01/2022 - 03/2016
2	Institutionalization (Institutionalized Persons) 01/2020 - 01/2020